The Patent Finder

Terms ending in 2037

Pfizer Inc.

Every in-force patent on Pfizer Inc.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,590,1286,7,8,9-Tetrahydro-5H-pyrido[2,3-d]azepine Dopamine D3 Ligands
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 11,390,6236,7,8,9-Tetrahydro-5H-pyrido[2,3-d]azepine Dopamine D3 Ligands
In force
 · Medium confidence
Pfizer Inc.In forceMedium confidence
US 10,221,242Antibodies Specific for Epidermal Growth Factor Receptor Variant III and Their Uses
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 10,259,876Chimeric Antigen Receptors Targeting Epidermal Growth Factor Receptor Variant III
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 10,869,924PD-L1 Antagonist Combination Treatments
In force
 · High confidence
Merck Patent GmbHIn forceHigh confidence
US 10,723,727Tubulysin Analogs and Methods for Their Preparation
In force
 · High confidence
Pfizer Healthcare IrelandIn forceHigh confidence
US 10,323,0426,7-Dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide Compounds
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 10,738,0636,7-Dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide Compounds
In force
 · Medium confidence
Pfizer Inc.In forceMedium confidence
US 10,144,738Pyrazolo[1,5-a]pyrazin-4-yl Derivatives
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 10,822,341Pyrazolo[1,5-a]pyrazin-4-yl Derivatives
In force
 · Medium confidence
Pfizer Inc.In forceMedium confidence
48 more term ends in 2037 · Pro
10 of 58 patents shown. Soonest term end first, then patent number.
Pro members see all 58.
Upgrade to Pro
55 of these are in force and held by Pfizer Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited